# Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334

> **NCT04086602** · PHASE1 · COMPLETED · sponsor: **Inflazome UK Ltd** · enrollment: 64 (actual)

## Conditions studied

- Healthy Volunteers
- Cryopyrin Associated Periodic Syndrome

## Interventions

- **DRUG:** IZD334
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04086602
- **Lead sponsor:** Inflazome UK Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-13
- **Primary completion:** 2020-02-04
- **Final completion:** 2020-02-04
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2020-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04086602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04086602, "Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04086602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*